Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers

Lipids are critical for maintaining homeostasis and cellular metabolism. However, the dysregulation of lipid metabolism contributes to the pathogenesis of chronic inflammatory diseases and is a hallmark of several cancer types. Tumours exist in a microenvironment of poor vascularization-depleted oxy...

Full description

Bibliographic Details
Main Authors: Carmen Tse, Ashleigh Warner, Rufaik Farook, James G Cronin
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/8/1118
_version_ 1797561101185974272
author Carmen Tse
Ashleigh Warner
Rufaik Farook
James G Cronin
author_facet Carmen Tse
Ashleigh Warner
Rufaik Farook
James G Cronin
author_sort Carmen Tse
collection DOAJ
description Lipids are critical for maintaining homeostasis and cellular metabolism. However, the dysregulation of lipid metabolism contributes to the pathogenesis of chronic inflammatory diseases and is a hallmark of several cancer types. Tumours exist in a microenvironment of poor vascularization-depleted oxygen and restricted nutrients. Under these conditions, tumours have been shown to increasingly depend on the metabolism of fatty acids for sustained proliferation and survival. Signal transducer and activator of transcription 3 (STAT3) plays a key role in cellular processes such as cell growth, apoptosis and lipid metabolism. Aberrant STAT3 activity, as seen in several cancer types, is associated with tumour progression and malignancy, in addition to propagating crosstalk between tumour cells and the microenvironment. Furthermore, STAT3-regulated lipid metabolism is critical for cancer stem cell self-renewal and therapy resistance. Plant-derived compounds known as phytochemicals are a potential source for novel cancer therapeutic drugs. Dietary phytochemicals are known to modulate key cellular signalling pathways involved in lipid homeostasis and metabolism, including the STAT3 signalling pathways. Targeting STAT3 orchestrated lipid metabolism has shown therapeutic promise in human cancer models. In this review, we summarize the antitumour activity of phytochemicals with an emphasis placed on their effect on STAT3-regulated lipid metabolism and their role in abrogating therapy resistance.
first_indexed 2024-03-10T18:09:31Z
format Article
id doaj.art-cf497419fbdc43bbb90a0c4246ce8573
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T18:09:31Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-cf497419fbdc43bbb90a0c4246ce85732023-11-20T08:16:56ZengMDPI AGBiomolecules2218-273X2020-07-01108111810.3390/biom10081118Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant CancersCarmen Tse0Ashleigh Warner1Rufaik Farook2James G Cronin3Immunometabolism & Cancer Research Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea SA2 8PP, Wales, UKImmunometabolism & Cancer Research Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea SA2 8PP, Wales, UKImmunometabolism & Cancer Research Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea SA2 8PP, Wales, UKImmunometabolism & Cancer Research Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea SA2 8PP, Wales, UKLipids are critical for maintaining homeostasis and cellular metabolism. However, the dysregulation of lipid metabolism contributes to the pathogenesis of chronic inflammatory diseases and is a hallmark of several cancer types. Tumours exist in a microenvironment of poor vascularization-depleted oxygen and restricted nutrients. Under these conditions, tumours have been shown to increasingly depend on the metabolism of fatty acids for sustained proliferation and survival. Signal transducer and activator of transcription 3 (STAT3) plays a key role in cellular processes such as cell growth, apoptosis and lipid metabolism. Aberrant STAT3 activity, as seen in several cancer types, is associated with tumour progression and malignancy, in addition to propagating crosstalk between tumour cells and the microenvironment. Furthermore, STAT3-regulated lipid metabolism is critical for cancer stem cell self-renewal and therapy resistance. Plant-derived compounds known as phytochemicals are a potential source for novel cancer therapeutic drugs. Dietary phytochemicals are known to modulate key cellular signalling pathways involved in lipid homeostasis and metabolism, including the STAT3 signalling pathways. Targeting STAT3 orchestrated lipid metabolism has shown therapeutic promise in human cancer models. In this review, we summarize the antitumour activity of phytochemicals with an emphasis placed on their effect on STAT3-regulated lipid metabolism and their role in abrogating therapy resistance.https://www.mdpi.com/2218-273X/10/8/1118STAT3lipidscancerphytochemical
spellingShingle Carmen Tse
Ashleigh Warner
Rufaik Farook
James G Cronin
Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
Biomolecules
STAT3
lipids
cancer
phytochemical
title Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
title_full Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
title_fullStr Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
title_full_unstemmed Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
title_short Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
title_sort phytochemical targeting of stat3 orchestrated lipid metabolism in therapy resistant cancers
topic STAT3
lipids
cancer
phytochemical
url https://www.mdpi.com/2218-273X/10/8/1118
work_keys_str_mv AT carmentse phytochemicaltargetingofstat3orchestratedlipidmetabolismintherapyresistantcancers
AT ashleighwarner phytochemicaltargetingofstat3orchestratedlipidmetabolismintherapyresistantcancers
AT rufaikfarook phytochemicaltargetingofstat3orchestratedlipidmetabolismintherapyresistantcancers
AT jamesgcronin phytochemicaltargetingofstat3orchestratedlipidmetabolismintherapyresistantcancers